발작과 실신에서 일시적 혈중 암모니아 상승의 차이
Differential Diagnostic Value of Transient Increase of Plasma Ammonia Level in Seizure and Syncope
5
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Differential diagnosis between a generalized tonic-clonic seizure and syncope may be difficult due to similar clinical features. The need for a biological marker to distinguish a seizure from syncope has been emphasized from past studies. Transient hyperammonemia could be an indicator of recent convulsive seizure. The purpose of this study is to review the use of plasma ammonia level in the differential diagnosis of seizure and syncope. Methods: Adult patients who were admitted to the Department of Neurology at Gangnam Severance Hospital with final diagnosis of a generalized tonic-clonic seizure or syncope were eligible for this study. Plasma ammonia levels were checked within 8 hr after an insult. Results: Among the patients with a loss of consciousness who underwent analysis of plasma ammonia level, diagnoses were made with a seizure (n=65) and syncope (n=38). The seizure group had 70.29±70.86 μmol/L and the syncope group had 28.37±10.27 μmol/L of ammonia level, respectively. The seizure group presented with a significantly increased plasma ammonia (p<0.05) compared to the syncope group. The cut-off value with the reliable diagnostic level was defined as 36 μmol/L (=61.308 μg/dL) with a sensitivity of 0.65 and specificity of 0.80 by receiver operating characteristic (ROC) curve analysis. Conclusions: Plasma ammonia measurement during acute post-ictal period may be a useful test for the identification and the differential diagnosis of seizures and syncope.
Abstract
Background: Differential diagnosis between a generalized tonic-clonic seizure and syncope may be difficult due to similar clinical features. The need for a biological marker to distinguish a seizure from syncope has been emphasized from past studies. Transient hyperammonemia could be an indicator of recent convulsive seizure. The purpose of this study is to review the use of plasma ammonia level in the differential diagnosis of seizure and syncope. Methods: Adult patients who were admitted to the Department of Neurology at Gangnam Severance Hospital with final diagnosis of a generalized tonic-clonic seizure or syncope were eligible for this study. Plasma ammonia levels were checked within 8 hr after an insult. Results: Among the patients with a loss of consciousness who underwent analysis of plasma ammonia level, diagnoses were made with a seizure (n=65) and syncope (n=38). The seizure group had 70.29±70.86 μmol/L and the syncope group had 28.37±10.27 μmol/L of ammonia level, respectively. The seizure group presented with a significantly increased plasma ammonia (p<0.05) compared to the syncope group. The cut-off value with the reliable diagnostic level was defined as 36 μmol/L (=61.308 μg/dL) with a sensitivity of 0.65 and specificity of 0.80 by receiver operating characteristic (ROC) curve analysis. Conclusions: Plasma ammonia measurement during acute post-ictal period may be a useful test for the identification and the differential diagnosis of seizures and syncope.
참고문헌 (33)
- McKeon A, "Seizure versus syncope", Lancet Neuroly, 5, pp.171~180 (2006)
- Bergfeldt L, "Differential diagnosis of cardiogenic syncope and seizure disorders", Heart, 89, pp.353~358 (2003)
- Britton JW, "Seizures and syncope: anatomic basis and diagnostic considerations", Clin Auton Res, 16, pp.18~28 (2006)
- Sheldon R, "Historical criteria that distinguish syncope from seizures", J Am Coll Cardiol, 40, pp.142~148 (2002)
- Bauer J, "Epilepsy and prolactin in adults: a clinical review", Epilepsy Res, 24, pp.1~7 (1996)
- Chen DK, "Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.", Neurology, 65, pp.668~675 (2005)
- LaFrance WC Jr, "Use of serum prolactin in diagnosing epileptic seizures: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology", Neurology, 66, pp.1287~1288 (2006)
- Petramfar P, "Serum creatine phosphokinase is helpful in distinguishing generalized tonic-clonic seizures from psychogenic nonepileptic seizures and vasovagal syncope", Epilepsy Behav, 15, pp.330~332 (2009)
- Goksu E, "Seizure or syncope: the diagnostic value of serum creatine kinase and myoglobin levels", Eur J Emerg Med, 16, pp.84~86 (2009)
- Libman MD, "Seizure vs. syncope: measuring serum creatine kinase in the emergency department", J Gen Intern Med, 6, pp.408~412 (1991)
- Bakes KM, "The Denver Seizure Score: anion gap metabolic acidosis predicts generalized seizure", Am J Emerg Med, 29, pp.1097~1102 (2011)
- Lee SY, "Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope", J Neurol, 257, pp.1708~1712 (2010)
- Weng TI, "Unusual causes of hyperammonemia in the ED", Am J Emerg Med, 22, pp.105~107 (2004)
- Wilkinson DJ, "Ammonia metabolism, the brain and fatigue; revisiting the link", Prog Neurobiol, 91, pp.200~219 (2010)
- Yanagawa Y, "Hyperammonemia is associated with generalized convulsion", Intern Med, 47, pp.21~23 (2008)
- Liu KT, "Postictal transient hyperammonemia as an indicator of seizure disorder", Eur Neurol, 64, pp.46~50 (2010)
- Hung TY, "Transient hyperammonemia in seizures: a prospective study", Epilepsia, 52, pp.2043~2049 (2011)
- Tomita K, "Clinical significance of plasma ammonia in patients with generalized convulsion", Intern Med, 50, pp.2297~2301 (2011)
- Butterworth RF., "Pathophysiology of hepatic encephalopathy: a new look at ammonia", MetabBrain Dis, 17, pp.221~227 (2002)
- Clay AS, "Hyperammonemia in the ICU", Chest, 132, pp.1368~1378 (2007)
- McPhail MJ, "Pathogenesis and diagnosis of hepatic encephalopathy", Expert Rev Gastroenterol Hepatol, 4, pp.365~378 (2010)
- van Donselaar CA, "Value of the electroencephalogram in adult patients with untreated idiopathic first seizures", Arch Neurol, 49, pp.231~ (1992)
- King MA, "Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients", Lancet, 352, pp.1007~1011 (1998)
- Bachmann C., "Mechanisms of hyperammonemia", Clin Chem Lab Med, 40, pp.653~662 (2005)
- Banister EW, "Exercise-induced hyperammonemia: peripheral and central effects", Int J Sports Med, 11, pp.129~142 (1990)
- Hasselblatt M, "Persistent disturbance of the hypothalamic-pituitary-gonadal axis in abstinent alcoholic men", Alcohol Alcohol, 38, pp.239~242 (2003)
- Kumar V, "Human muscle protein synthesis and breakdown during and after exercise", J Appl Physiol, 106, pp.2026~2039 (2009)
- Hawkes N, "Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy", Postgrad Med J, 77, pp.717~722 (2001)
- Lowenstein JM., "Ammonia production in muscle and other tissues: the purine nucleotide cycle", Physiol Rev, 52, pp.382~414 (1972)
- Mutch B, "Ammonia metabolism in exercise and fatigue: a review", Med Sci Sports Exerc, 15, pp.41~50 (1983)
- Bongaerts G, "Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy", Med Hypotheses, 64, pp.64~68 (2005)
- Phongsamran PV, "Pharmacotherapy for hepatic encephalopathy", Drugs, 70, pp.1131~1148 (2010)
- Romero-Góomez M, "Pharmacotherapy of hepatic encephalopathy in cirrhosis", Expert Opin Pharmacother, 11, pp.1317~1327 (2010)